Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Zogenix (Zohydro business)

M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Provider of pharmaceutical products. The unit provides opioid agonist, extended-release, oral formulation of hydrocodone bitartrate indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
  • CA
  • United States

Zogenix (Zohydro business) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Zogenix (Zohydro business)‘s full profile, request access.

Request full access to PitchBook

Zogenix (Zohydro business) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Zogenix (Zohydro business)‘s full profile, request access.

Request full access to PitchBook